Third Pole develops products that generate and deliver electric nitric oxide for hospital, ambulatory, and home use.
The Third Pole core technology is an innovative clean, tankless inhaled Nitric Oxide (NO) proven equivalent to marketed tank-gas in the lab. Nitric oxide saves hypoxic newborns, but is available only in a limited number of countries, for those who can afford it, by physicians who have access to the product.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 14, 2022 | Series B | $32M | — | — | — | Detail |
Feb 3, 2022 | Funding Round | $25M | — | — | — | Detail |
Apr 15, 2021 | Debt Financing | $15M | 1 | Avenue Capital Group | — | Detail |
Dec 28, 2017 | Series Unknown | — | 1 | — | — | Detail |
Dec 23, 2015 | Series Unknown | $13.75M | — | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Avenue Capital Group | Yes | Debt Financing |
Saturn Partners | — | Series Unknown |